Fifth Third Bancorp Amphastar Pharmaceuticals, Inc. Transaction History
Fifth Third Bancorp
- $27.1 Billion
- Q4 2024
A detailed history of Fifth Third Bancorp transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Fifth Third Bancorp holds 423 shares of AMPH stock, worth $11,805. This represents 0.0% of its overall portfolio holdings.
Number of Shares
423
Previous 633
33.18%
Holding current value
$11,805
Previous $30,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding AMPH
# of Institutions
275Shares Held
35.2MCall Options Held
26.5KPut Options Held
7.9K-
Black Rock Inc. New York, NY5.94MShares$166 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.71MShares$75.8 Million0.0% of portfolio
-
Td Asset Management Inc1.84MShares$51.4 Million0.06% of portfolio
-
State Street Corp Boston, MA1.6MShares$44.5 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY1.37MShares$38.4 Million0.04% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.37B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...